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Predicting mortality has been a corner piece of critical
care research and practise dating back to the first
descriptions of the Acute Physiology and Chronic Health
Evaluation score in 1981 [1]. With an increasing burden
of non-communicable disease in modern society, pre-
existing functional status seems to an important
contributor to outcome prediction. Poor physical func-
tion is an important predictor of mortality in ambulant
diseases. The construct of frailty [2], translated from
older patient care into critical care, has provided a useful
language to discuss pre-morbid functional status.
Whilst frailty can be established from history taking or
hospital coding, both of these methods have clinical and
research methodological disadvantages. Wilhelmus et al.
[3] now offer an alternative approach in a retrospective
analysis of computerized tomography scans. Muscle
quality as defined by Hounsfield units at the level of L3
was investigated in 491 patients, with a threshold set to
define intramuscular adipose tissue and visceral adipose
tissue. Higher skeletal muscle density (i.e. better quality)
was associated with lower 6-month mortality and
shorter hospital length of stay after correction for
muscle mass and severity of illness.
Skeletal muscle quality is recognized as a marker of
function in healthy individuals [4] and critically ill patients
[5]. Alterations are seen with aging [4], immobilization
[6], chronic disease states [7] and critical illness [8]. These
conditions demonstrate qualitative changes in muscle
structure as a result of increasing collagen and lipid
deposition [6]. Intramyocellular lipid accumulation is
additionally a hallmark of metabolic diseases, and
may exacerbate tissue metabolic derangements in the
critically ill.
A limitation of these data is the inability to relate
either chronic disease states and poor muscle quality, or
muscle quality and functional outcomes. However,
decreased skeletal muscle density as an independent pre-
dictor of mortality raises the possibility of its use in
multi-dimensional scoring systems such as the NUTRIC
score [9] or as an alternative marker of chronic poor
physiological reserve in the APACHE system.
A number of key roles for early trajectory assessments
exist. First, novel early outcome predictors are needed to
guide patient and family expectations and decision-
making. These need to not only predict risk of death,
but also disability, so a patient’s wishes may be honoured
and a realistic appraisal of functional outcomes can be
made. It is vital we improve upon our ability to inform
patients and families early in critical illness on the likeli-
hood of significant morbidity. It is possible that admis-
sion skeletal muscle quality and quantity may be key to
this discussion in the future. Ongoing testing via lean
body mass ultrasound [8] and other modalities [10] may
also be vital to continued discussions of prognosis.
Second, these tests of muscle quality should assist in
guiding therapy. A recent post-ICU recovery consensus
conference indicated that a major gap exists in under-
standing how to effectively and efficiently screen patients
for specific post-ICU impairments to determine the need
for further diagnostic work-up and treatment [11].
Thirdly, the current controversy around personalizing
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nutrition delivery in the ICU to optimize outcome [12]
has begun to be addressed by early studies validating the
role of the aforementioned NUTRIC score in nutrition
risk prediction [9]. High malnutrition risk patients may
benefit to a greater degree than those with lower risk. A
key addition to this prediction of nutrition risk may be
muscle quantity and quality at ICU admission. The abil-
ity of the muscle to utilize substrate such as lipid and
overall glycogen content [10] may be key in delivering
personalized nutrition to improve outcomes. Patients with
low muscle quality and quantity may have greater and
different specific nutritional requirements. Conversely,
increased muscle myosteatosis as defined by decreased
skeletal muscle density or increased intermuscular adipose
tissue may indicate impaired muscle substrate utilization
as implied by Wilhelmus et al. [3]. This may indicate that
nutrition delivery needs to account for impaired substrate
(lipid) utilization and/or measures need to be taken to im-
prove muscle lipid uptake/utilization (e.g. carnitine [13]).
Finally, exercise and reduction of immobility are essential
to reduce impaired muscle substrate metabolism and thus
improve poor muscle quality.
These assessments may be a key innovation prior to
major surgery or cancer therapy. Patients with poor
skeletal muscle quality could then be enrolled in preha-
bilitative exercise/nutrition programmes to improve
skeletal muscle quality and quantity [14]. Clinical trials
systematically evaluating muscle quality and quantity
measures via CT scan and ultrasound could then be per-
formed to assess interventions and target ideal methods
to optimize patients. Further, in the ICU, these tech-
niques need further study to determine the muscle-level
effects of individual nutrition (e.g. protein delivery,
anabolic agents [10]) and specific ICU-rehabilitation in-
terventions (e.g. in-bed ergometry, functional electrical
stimulation [15]). Current functional testing (i.e. Medical
Research Council sum score, hand-grip strength, walk
testing) is both volitional and not muscle specific, and
has significant implementation, interpretation and com-
pliance challenges. Thus, the role of muscle quality and
quantity measurement described here deserves add-
itional study and validation to add an additional “dimen-
sion” to our prediction of outcome and personalization
of care in the ICU.
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